1.
ERJ Open Res
; 9(6)2023 Nov.
Article
in English
| MEDLINE
| ID: mdl-38076674
ABSTRACT
Plasma levels of α1-antitrypsin-derived C-terminal peptides might be valid as novel biomarkers to predict and/or characterise exacerbations in PiMM and PiZZ COPD patients, or to reflect the efficiency of augmentation therapy in PiZZ patients https://bit.ly/3rNJeLd.
